|40.67||-0.25 / -0.61%|
As of 4:00pm ET
|40.67||0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for Neurocrine Biosciences Inc have a median target of 40.00, with a high estimate of 45.00 and a low estimate of 39.00. The median estimate represents a -1.65% decrease from the last price of 40.67.
The current consensus among 7 polled investment analysts is to Buy stock in Neurocrine Biosciences Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.